Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

The neuropsychology of ecstasy (MDMA) use: a quantitative review.

Zakzanis KK, Campbell Z, Jovanovski D.

Hum Psychopharmacol. 2007 Oct;22(7):427-35. Review.

PMID:
17896346
2.

MDMA use and neurocognition: a meta-analytic review.

Kalechstein AD, De La Garza R 2nd, Mahoney JJ 3rd, Fantegrossi WE, Newton TF.

Psychopharmacology (Berl). 2007 Jan;189(4):531-7. Epub 2006 Nov 3. Review.

PMID:
17082969
3.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479
4.

Long term psychiatric and cognitive effects of MDMA use.

McGuire P.

Toxicol Lett. 2000 Mar 15;112-113:153-6. Review.

PMID:
10720725
6.

Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.

Montoya AG, Sorrentino R, Lukas SE, Price BH.

Harv Rev Psychiatry. 2002 Jul-Aug;10(4):212-20. Review.

PMID:
12119307
7.
8.

The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.

Karlsen SN, Spigset O, Slørdal L.

Basic Clin Pharmacol Toxicol. 2008 Jan;102(1):15-24. Epub 2007 Nov 28. Review.

9.

Ecstasy (MDMA): a review of its possible persistent psychological effects.

Morgan MJ.

Psychopharmacology (Berl). 2000 Oct;152(3):230-48. Review.

PMID:
11105933
10.

[Psychiatric and cognitive long-term effects of ecstasy].

Høiseth G, Løvåsdal Ø, Titze TK, Bramness JG, Bachs L.

Tidsskr Nor Laegeforen. 2006 Feb 23;126(5):596-8. Review. Norwegian.

11.

A review of the acute subjective effects of MDMA/ecstasy.

Baylen CA, Rosenberg H.

Addiction. 2006 Jul;101(7):933-47. Review.

PMID:
16771886
12.

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.

Gouzoulis-Mayfrank E, Daumann J.

J Psychopharmacol. 2006 Mar;20(2):188-93. Review.

PMID:
16510477
13.
14.

MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.

Parrott AC.

Neurosci Biobehav Rev. 2013 Sep;37(8):1466-84. doi: 10.1016/j.neubiorev.2013.04.016. Epub 2013 May 6. Review.

PMID:
23660456
15.

3,4-methylenedioxymethamphetamine (MDMA): a review.

O'Leary G, Nargiso J, Weiss RD.

Curr Psychiatry Rep. 2001 Dec;3(6):477-83. Review.

PMID:
11707161
16.

Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.

Garg A, Kapoor S, Goel M, Chopra S, Chopra M, Kapoor A, McCann UD, Behera C.

Curr Drug Abuse Rev. 2015;8(1):15-25. Review.

PMID:
25731754
18.

Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.

Parrott AC.

Hum Psychopharmacol. 2013 Jul;28(4):289-307. doi: 10.1002/hup.2318. Review.

PMID:
23881877
19.

The effects of 'ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses.

Murphy PN, Bruno R, Ryland I, Wareing M, Fisk JE, Montgomery C, Hilton J.

Hum Psychopharmacol. 2012 Mar;27(2):113-38. doi: 10.1002/hup.1270. Review.

PMID:
22389076
20.

A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response.

Green AR, O'shea E, Colado MI.

Eur J Pharmacol. 2004 Oct 1;500(1-3):3-13. Review.

PMID:
15464016

Supplemental Content

Support Center